Diet-induced obesity up-regulates the abundance of GPR43 and GPR120 in a tissue specific manner

Cellular Physiology and Biochemistry

Volumn 28, Issue 5, 2011, Pages 949-958

  Cornall, Lauren M ^a   Mathai, Michael L ^a,b   Hryciw, Deanne H ^a   McAinch, Andrew J ^a  

^a VICTORIA UNIVERSITY   (Australia)

^b UNIVERSITY OF MELBOURNE   (Australia)

Author keywords

GPR120; GPR43; Heart; Liver; mRNA; Obesity; Skeletal muscle; Type 2 diabetes mellitus

Indexed keywords

G PROTEIN COUPLED RECEPTOR; G PROTEIN COUPLED RECEPTOR 120; G PROTEIN COUPLED RECEPTOR 43; MESSENGER RNA; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; EXTENSOR DIGITORUM LONGUS MUSCLE; GENE EXPRESSION; GENETIC TRANSCRIPTION; HEART MUSCLE; LIPID DIET; LIVER; MALE; NONHUMAN; OBESITY; PRIORITY JOURNAL; RAT; REAL TIME POLYMERASE CHAIN REACTION; RECEPTOR UPREGULATION; SOLEUS MUSCLE; TISSUE METABOLISM;

EID: 83755225879     PISSN: 10158987     EISSN: 14219778     Source Type: Journal    
DOI: 10.1159/000335820     Document Type: Article

References (79)

1. Seidell JC: Obesity, insulin resistance and diabetes-a worldwide epidemic. Br J Nutr 2000;83:S5-8. (Pubitemid 30319075)
2. Bonow RO, Smaha LA, Smith SC Jr, Mensah GA, Lenfant C: World Heart Day 2002: the international burden of cardiovascular disease: responding to the emerging global epidemic. Circulation 2002;106:1602-1605.
3. Hu FB: Globalization of Diabetes: The role of diet, lifestyle, and genes. Diabetes Care 2011;34:1249-1257.
4. Dorn JM, Schisterman EF, Winkelstein W Jr, Trevisan M: Body mass index and mortality in a general population sample of men and women. The Buffalo Health Study. Am J Epidemiol 1997;146:919-931.
5. Rosengren A, Wedel H, Wilhelmsen L: Body weight and weight gain during adult life in men in relation to coronary heart disease and mortality. A prospective population study. Eur Heart J 1999;20:269-277. (Pubitemid 29082147)
6. Kristiansen K: Molecular mechanisms of ligand binding, signaling, and regulation within the superfamily of G-proteincoupled receptors: molecular modeling and mutagenesis approaches to receptor structure and function. Pharmacol Ther 2004;103:21-80. (Pubitemid 38891912)
7. Wellendorph P, Johansen LD, Brauner-Osborne H: Molecular pharmacology of promiscuous seven transmembrane receptors sensing organic nutrients. Mol Pharmacol 2009;76:453-465.
8. Bockaert J, Pin JP: Molecular tinkering of G protein-coupled receptors: an evolutionary success. EMBO J 1999;18:1723-1729. (Pubitemid 29158516)
9. Lagerstrom MC, Schioth HB: Structural diversity of G protein-coupled receptors and significance for drug discovery. Nat Rev Drug Discov 2008;7:339-357.
10. Lundstrom K: Latest development in drug discovery on G protein-coupled receptors. Curr Protein Pept Sci 2006;7:465-470. (Pubitemid 44524494)
11. Sawzdargo M, George SR, Nguyen T, Xu S, Kolakowski LF, O'Dowd BF: A cluster of four novel human G protein-coupled receptor genes occurring in close proximity to CD22 gene on chromosome 19q13.1. Biochem Biophys Res Commun 1997;239:543-547. (Pubitemid 27489000)
12. Fredriksson R, Hoglund PJ, Gloriam DE, Lagerstrom MC, Schioth HB: Seven evolutionarily conserved human rhodopsin G protein-coupled receptors lacking close relatives. FEBS Lett 2003;554:381-388. (Pubitemid 37412518)
13. Brown AJ, Goldsworthy SM, Barnes AA, Eilert MM, Tcheang L, Daniels D, Muir AI, Wigglesworth MJ, Kinghorn I, Fraser NJ, Pike NB, Strum JC, Steplewski KM, Murdock PR, Holder JC, Marshall FH, Szekeres PG, Wilson S, Ignar DM, Foord SM, Wise A, Dowell SJ: The Orphan G protein-coupled receptors GPR41 and GPR43 are activated by propionate and other short chain carboxylic acids. J Biol Chem 2003;278:11312-11319. (Pubitemid 36792688)
14. Le Poul E, Loison C, Struyf S, Springael JY, Lannoy V, Decobecq ME, Brezillon S, Dupriez V, Vassart G, Van Damme J, Parmentier M, Detheux M: Functional characterization of human receptors for short chain fatty acids and their role in polymorphonuclear cell activation. J Biol Chem 2003;278:25481-25489. (Pubitemid 36835299)
15. Burns RN, Moniri NH: Agonism with the omega-3 fatty acids alpha-linolenic acid and docosahexaenoic acid mediates phosphorylation of both the short and long isoforms of the human GPR120 receptor. Biochem Biophys Res Commun 2010;396:1030-1035.
16. Oh DY, Talukdar S, Bae EJ, Imamura T, Morinaga H, Fan W, Li P, Lu WJ, Watkins SM, Olefsky JM: GPR120 is an omega-3 fatty acid receptor mediating potent anti-inflammatory and insulin-sensitizing effects. Cell 2010;142:687-698.
17. Hirasawa A, Tsumaya K, Awaji T, Katsuma S, Adachi T, Yamada M, Sugimoto Y, Miyazaki S, Tsujimoto G: Free fatty acids regulate gut incretin glucagon-like peptide-1 secretion through GPR120. Nat Med 2005;11:90-94. (Pubitemid 40215843)
18. Wolfe RR, Klein S, Carraro F, Weber JM: Role of triglyceride-fatty acid cycle in controlling fat metabolism in humans during and after exercise. Am J Physiol 1990;258:E382-389. (Pubitemid 20094655)
19. Chawla A, Repa JJ, Evans RM, Mangelsdorf DJ: Nuclear receptors and lipid physiology: opening the X-files. Science 2001;294:1866-1870. (Pubitemid 33101573)
20. Duplus E, Forest C: Is there a single mechanism for fatty acid regulation of gene transcription Biochem Pharmacol 2002;64:893-901. (Pubitemid 35232263)
21. Maslowski KM, Vieira AT, Ng A, Kranich J, Sierro F, Yu D, Schilter HC, Rolph MS, Mackay F, Artis D, Xavier RJ, Teixeira MM, Mackay CR: Regulation of inflammatory responses by gut microbiota and chemoattractant receptor GPR43. Nature 2009;461:1282-1286.
22. Nilsson NE, Kotarsky K, Owman C, Olde B: Identification of a free fatty acid receptor, FFA2R, expressed on leukocytes and activated by short-chain fatty acids. Biochem Biophys Res Commun 2003;303:1047-1052. (Pubitemid 36390250)
23. Hong YH, Nishimura Y, Hishikawa D, Tsuzuki H, Miyahara H, Gotoh C, Choi KC, Feng DD, Chen C, Lee HG, Katoh K, Roh SG, Sasaki S: Acetate and propionate short chain fatty acids stimulate adipogenesis via GPCR43. Endocrinology 2005;146:5092-5099. (Pubitemid 41653022)
24. Karaki S, Mitsui R, Hayashi H, Kato I, Sugiya H, Iwanaga T, Furness JB, Kuwahara A: Short-chain fatty acid receptor, GPR43, is expressed by enteroendocrine cells and mucosal mast cells in rat intestine. Cell Tissue Res 2006;324:353-360. (Pubitemid 43673476)
25. Zaibi MS, Stocker CJ, O'Dowd J, Davies A, Bellahcene M, Cawthorne MA, Brown AJ, Smith DM, Arch JR: Roles of GPR41 and GPR43 in leptin secretory responses of murine adipocytes to short chain fatty acids. FEBS Lett 2010;584:2381-2386.
26. Gotoh C, Hong YH, Iga T, Hishikawa D, Suzuki Y, Song SH, Choi KC, Adachi T, Hirasawa A, Tsujimoto G, Sasaki S, Roh SG: The regulation of adipogenesis through GPR120. Biochem Biophys Res Commun 2007;354:591-597. (Pubitemid 46161365)
27. Ge H, Li X, Weiszmann J, Wang P, Baribault H, Chen JL, Tian H, Li Y: Activation of G protein-coupled receptor 43 in adipocytes leads to inhibition of lipolysis and suppression of plasma free fatty acids. Endocrinology 2008;149:4519-4526.
28. Kaji I, Karaki S, Tanaka R, Kuwahara A: Density distribution of free fatty acid receptor 2 (FFA2)-expressing and GLP-1-producing enteroendocrine L cells in human and rat lower intestine, and increased cell numbers after ingestion of fructo-oligosaccharide. J Mol Histol 2011;42:27-38.
29. Tanaka T, Katsuma S, Adachi T, Koshimizu TA, Hirasawa A, Tsujimoto G: Free fatty acids induce cholecystokinin secretion through GPR120. Naunyn Schmiedebergs Arch Pharmacol 2008;377:523-527.
30. Tanaka T, Yano T, Adachi T, Koshimizu TA, Hirasawa A, Tsujimoto G: Cloning and characterization of the rat free fatty acid receptor GPR120: in vivo effect of the natural ligand on GLP-1 secretion and proliferation of pancreatic beta cells. Naunyn Schmiedebergs Arch Pharmacol 2008;377:515-522.
31. Sina C, Gavrilova O, Forster M, Till A, Derer S, Hildebrand F, Raabe B, Chalaris A, Scheller J, Rehmann A, Franke A, Ott S, Hasler R, Nikolaus S, Folsch UR, Rose-John S, Jiang HP, Li J, Schreiber S, Rosenstiel P: G protein-coupled receptor 43 is essential for neutrophil recruitment during intestinal inflammation. J Immunol 2009;183:7514-7522.
32. Li ZY, Wang P, Miao CY: Adipokines in inflammation, insulin resistance and cardiovascular disease. Clin Exp Pharmacol Physiol 2011;in press.
33. Zurlo F, Larson K, Bogardus C, Ravussin E: Skeletal muscle metabolism is a major determinant of resting energy expenditure. J Clin Invest 1990;86:1423-1427. (Pubitemid 20372586)
34. Baron AD, Brechtel G, Wallace P, Edelman SV: Rates and tissue sites of noninsulin-and insulin-mediated glucose uptake in humans. Am J Physiol 1988;255:E769-774.
35. Kelley DE, Williams KV, Price JC, McKolanis TM, Goodpaster BH, Thaete FL: Plasma fatty acids, adiposity, and variance of skeletal muscle insulin resistance in type 2 diabetes mellitus. J Clin Endocrinol Metab 2001;86:5412-5419. (Pubitemid 33070268)
36. Kim JY, Hickner RC, Cortright RL, Dohm GL, Houmard JA: Lipid oxidation is reduced in obese human skeletal muscle. Am J Physiol Endocrinol Metab 2000;279:E1039-1044.
37. Zammit VA: Role of insulin in hepatic fatty acid partitioning: emerging concepts. Biochem J 1996;314:1-14. (Pubitemid 26063826)
38. Weickert MO, Pfeiffer AF: Signalling mechanisms linking hepatic glucose and lipid metabolism. Diabetologia 2006;49:1732-1741. (Pubitemid 44025026)
39. Young ME, McNulty P, Taegtmeyer H: Adaptation and maladaptation of the heart in diabetes: Part II: potential mechanisms. Circulation 2002;105:1861-1870. (Pubitemid 34408899)
40. Mathai ML, Naik S, Sinclair AJ, Weisinger HS, Weisinger RS: Selective reduction in body fat mass and plasma leptin induced by angiotensin-converting enzyme inhibition in rats. Int J Obes (Lond) 2008;32:1576-1584.
41. Hindle AK, Brody F, Tevar R, Kluk B, Hill S, McCaffrey T, Fu S: TCF7L2 expression in diabetic patients undergoing bariatric surgery. Surg Endosc 2009;23:700-704.
42. Livak KJ, Schmittgen TD: Analysis of relative gene expression data using realtime quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods 2001;25:402-408. (Pubitemid 34164012)
43. Bjursell M, Admyre T, Goransson M, Marley AE, Smith DM, Oscarsson J, Bohlooly YM: Improved glucose control and reduced body fat mass in free fatty acid receptor 2-deficient mice fed a highfat diet. Am J Physiol Endocrinol Metab 2011;300:E211-220.
44. Yonezawa T, Kobayashi Y, Obara Y: Short-chain fatty acids induce acute phosphorylation of the p38 mitogenactivated protein kinase/heat shock protein 27 pathway via GPR43 in the MCF-7 human breast cancer cell line. Cell Signal 2007;19:185-193. (Pubitemid 44880254)
45. Green CJ, Macrae K, Fogarty S, Hardie DG, Sakamoto K, Hundal HS: Counter modulation of fatty acid-induced proinflammatory NFB signalling in rat skeletal muscle cells by AMPK. Biochem J 2011;435:463-474.
46. Coll T, Jove M, Rodriguez-Calvo R, Eyre E, Palomer X, Sanchez RM, Merlos M, Laguna JC, Vazquez-Carrera M: Palmitate-mediated downregulation of peroxisome proliferator-activated receptor-gamma coactivator 1alpha in skeletal muscle cells involves MEK1/2 and nuclear factor-kappaB activation. Diabetes 2006;55:2779-2787. (Pubitemid 44923677)
47. Sparks LM, Xie H, Koza RA, Mynatt R, Hulver MW, Bray GA, Smith SR: A highfat diet coordinately downregulates genes required for mitochondrial oxidative phosphorylation in skeletal muscle. Diabetes 2005;54:1926-1933. (Pubitemid 40911253)
48. Wende AR, Huss JM, Schaeffer PJ, Giguere V, Kelly DP: PGC-1alpha coactivates PDK4 gene expression via the orphan nuclear receptor ERRalpha: A mechanism for transcriptional control of muscle glucose metabolism. Mol Cell Biol 2005;25:10684-10694. (Pubitemid 41747115)
49. Arany Z, He H, Lin J, Hoyer K, Handschin C, Toka O, Ahmad F, Matsui T, Chin S, Wu PH, Rybkin, II, Shelton JM, Manieri M, Cinti S, Schoen FJ, Bassel-Duby R, Rosenzweig A, Ingwall JS, Spiegelman BM: Transcriptional coactivator PGC-1 alpha controls the energy state and contractile function of cardiac muscle. Cell Metab 2005;1:259-271. (Pubitemid 43960608)
50. St-Pierre J, Lin J, Krauss S, Tarr PT, Yang R, Newgard CB, Spiegelman BM: Bioenergetic analysis of peroxisome proliferator-activated receptor gamma coactivators 1alpha and 1beta (PGC-1alpha and PGC-1beta) in muscle cells. J Biol Chem 2003;278:26597-26603. (Pubitemid 36876804)
51. Koves TR, Li P, An J, Akimoto T, Slentz D, Ilkayeva O, Dohm GL, Yan Z, Newgard CB, Muoio DM: Peroxisome proliferator-activated receptor-gamma co-activator 1alpha-mediated metabolic remodeling of skeletal myocytes mimics exercise training and reverses lipidinduced mitochondrial inefficiency. J Biol Chem 2005;280:33588-33598. (Pubitemid 41397160)
52. Patti ME, Butte AJ, Crunkhorn S, Cusi K, Berria R, Kashyap S, Miyazaki Y, Kohane I, Costello M, Saccone R, Landaker EJ, Goldfine AB, Mun E, DeFronzo R, Finlayson J, Kahn CR, Mandarino LJ: Coordinated reduction of genes of oxidative metabolism in humans with insulin resistance and diabetes: Potential role of PGC1 and NRF1. Proc Natl Acad Sci U S A 2003;100:8466-8471. (Pubitemid 36842568)
53. Vega RB, Huss JM, Kelly DP: The coactivator PGC-1 cooperates with peroxisome proliferator-activated receptor alpha in transcriptional control of nuclear genes encoding mitochondrial fatty acid oxidation enzymes. Mol Cell Biol 2000;20:1868-1876. (Pubitemid 30100203)
54. Lin J, Wu H, Tarr PT, Zhang CY, Wu Z, Boss O, Michael LF, Puigserver P, Isotani E, Olson EN, Lowell BB, Bassel-Duby R, Spiegelman BM: Transcriptional coactivator PGC-1 alpha drives the formation of slow-twitch muscle fibres. Nature 2002;418:797-801.
55. Jordan T, Jiang H, Li H, DiMario JX: Inhibition of ryanodine receptor 1 in fast skeletal muscle fibers induces a fast-toslow muscle fiber type transition. J Cell Sci 2004;117:6175-6183. (Pubitemid 40123981)
56. Tantiwong P, Shanmugasundaram K, Monroy A, Ghosh S, Li M, DeFronzo RA, Cersosimo E, Sriwijitkamol A, Mohan S, Musi N: NF-kappaB activity in muscle from obese and type 2 diabetic subjects under basal and exercisestimulated conditions. Am J Physiol Endocrinol Metab 2010;299:E794-801.
57. Sinha S, Perdomo G, Brown NF, O'Doherty RM: Fatty acid-induced insulin resistance in L6 myotubes is prevented by inhibition of activation and nuclear localization of nuclear factor kappa B. J Biol Chem 2004;279:41294-41301. (Pubitemid 39313568)
58. Fujishiro M, Gotoh Y, Katagiri H, Sakoda H, Ogihara T, Anai M, Onishi Y, Ono H, Funaki M, Inukai K, Fukushima Y, Kikuchi M, Oka Y, Asano T: MKK6/3 and p38 MAPK pathway activation is not necessary for insulin-induced glucose uptake but regulates glucose transporter expression. J Biol Chem 2001;276:19800-19806.
59. Somwar R, Kim DY, Sweeney G, Huang C, Niu W, Lador C, Ramlal T, Klip A: GLUT4 translocation precedes the stimulation of glucose uptake by insulin in muscle cells: potential activation of GLUT4 via p38 mitogen-activated protein kinase. Biochem J 2001;359:639-649. (Pubitemid 33063389)
60. Sweeney G, Somwar R, Ramlal T, Volchuk A, Ueyama A, Klip A: An inhibitor of p38 mitogen-activated protein kinase prevents insulin-stimulated glucose transport but not glucose transporter translocation in 3T3-L1 adipocytes and L6 myotubes. J Biol Chem 1999;274:10071-10078.
61. Ho RC, Alcazar O, Fujii N, Hirshman MF, Goodyear LJ: p38gamma MAPK regulation of glucose transporter expression and glucose uptake in L6 myotubes and mouse skeletal muscle. Am J Physiol Regul Integr Comp Physiol 2004;286:R342-349. (Pubitemid 38140379)
62. Mauvoisin D, Prevost M, Ducheix S, Arnaud MP, Mounier C: Key role of the ERK1/2 MAPK pathway in the transcriptional regulation of the Stearoyl-CoA Desaturase (SCD1) gene expression in response to leptin. Mol Cell Endocrinol 2010;319:116-128.
63. Mauvoisin D, Mounier C: Hormonal and nutritional regulation of SCD1 gene expression. Biochimie 2011;93:78-86.
64. Seo E, Park EJ, Park MK, Kim DK, Lee HJ, Hong SH: Differential Expression of Metabolism-related Genes in Liver of Diabetic Obese Rats. Korean J Physiol Pharmacol 2010;14:99-103.
65. Roth G, Kotzka J, Kremer L, Lehr S, Lohaus C, Meyer HE, Krone W, Muller-Wieland D: MAP kinases Erk1/2 phosphorylate sterol regulatory elementbinding protein (SREBP)-1a at serine 117 in vitro. J Biol Chem 2000;275:33302-33307.
66. Kotzka J, Muller-Wieland D, Roth G, Kremer L, Munck M, Schurmann S, Knebel B, Krone W: Sterol regulatory element binding proteins (SREBP)-1a and SREBP-2 are linked to the MAP-kinase cascade. J Lipid Res 2000;41:99-108. (Pubitemid 30051847)
67. Shimano H: Sterol regulatory elementbinding proteins (SREBPs): transcriptional regulators of lipid synthetic genes. Prog Lipid Res 2001;40:439-452. (Pubitemid 32929966)
68. Girgenrath S, Song K, Whittemore LA: Loss of myostatin expression alters fibertype distribution and expression of myosin heavy chain isoforms in slowand fast-type skeletal muscle. Muscle Nerve 2005;31:34-40. (Pubitemid 40053924)
69. Ariano MA, Armstrong RB, Edgerton VR: Hindlimb muscle fiber populations of five mammals. J Histochem Cytochem 1973;21:51-55.
70. Hultman E: Fuel selection, muscle fibre. Proc Nutr Soc 1995;54:107-121.
71. Katsuma S, Hatae N, Yano T, Ruike Y, Kimura M, Hirasawa A, Tsujimoto G: Free fatty acids inhibit serum deprivationinduced apoptosis through GPR120 in a murine enteroendocrine cell line STC-1. J Biol Chem 2005;280:19507-19515. (Pubitemid 41379471)
72. Reiter E, Lefkowitz RJ: GRKs and betaarrestins: roles in receptor silencing, trafficking and signaling. Trends Endocrinol Metab 2006;17:159-165.
73. Bueno OF, De Windt LJ, Tymitz KM, Witt SA, Kimball TR, Klevitsky R, Hewett TE, Jones SP, Lefer DJ, Peng CF, Kitsis RN, Molkentin JD: The MEK1-ERK1/2 signaling pathway promotes compensated cardiac hypertrophy in transgenic mice. EMBO J 2000;19:6341-6350.
74. Ueyama T, Kawashima S, Sakoda T, Rikitake Y, Ishida T, Kawai M, Yamashita T, Ishido S, Hotta H, Yokoyama M: Requirement of activation of the extracellular signal-regulated kinase cascade in myocardial cell hypertrophy. J Mol Cell Cardiol 2000;32:947-960. (Pubitemid 30663103)
75. Kehat I, Molkentin JD: Extracellular signal-regulated kinase 1/2 (ERK1/2) signaling in cardiac hypertrophy. Ann N Y Acad Sci 2010;1188:96-102.
76. de Simone G, Daniels SR, Devereux RB, Meyer RA, Roman MJ, de Divitiis O, Alderman MH: Left ventricular mass and body size in normotensive children and adults: assessment of allometric relations and impact of overweight. J Am Coll Cardiol 1992;20:1251-1260.
77. Singh R, Singh AP, Singh M, Krishan P: Impact of obesity on hypertensioninduced cardiac remodeling: role of oxidative stress and its modulation by gemfibrozil treatment in rats. Free Radic Biol Med 2011;50:363-370.
78. Gardin JM, Wagenknecht LE, Anton-Culver H, Flack J, Gidding S, Kurosaki T, Wong ND, Manolio TA: Relationship of cardiovascular risk factors to echocardiographic left ventricular mass in healthy young black and white adult men and women. The CARDIA study. Coronary Artery Risk Development in Young Adults. Circulation 1995;92:380-387.
79. Levy D, Garrison RJ, Savage DD, Kannel WB, Castelli WP: Prognostic implications of echocardiographically determined left ventricular mass in the Framingham Heart Study. N Engl J Med 1990;322:1561-1566. (Pubitemid 20176696)